Premier Biomedical, Inc. (OTCMKTS:BIEI – Get Free Report)’s share price crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $0.00 and traded as high as $0.0007. Premier Biomedical shares last traded at $0.0007, with a volume of 7,851,449 shares changing hands.
Premier Biomedical Trading Down 11.1%
About Premier Biomedical
Premier Biomedical, Inc is a biotechnology company focused on developing therapeutic products for conditions including pain, inflammation, cancer, and substance-use disorders. The company’s work has centered on proprietary formulations and drug-delivery approaches intended to provide alternatives to conventional treatments.
Premier Biomedical has historically operated as a development-stage business, emphasizing research, product formulation, and potential commercialization rather than maintaining a broad portfolio of established commercial products.
Further Reading
- Five stocks we like better than Premier Biomedical
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Premier Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Premier Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
